Dofetilide
Dofetilide is a pharmaceutical drug product manufactured by Merck Group. It is a class III antiarrhythmic agent used for the treatment of certain types of cardiac arrhythmias. The core function of Dofetilide is to help regulate and maintain a normal heart rhythm in patients diagnosed with these specific cardiac conditions.
Lab products found in correlation
22 protocols using dofetilide
Dofetilide and Derivative Preparation
Optical Mapping of Cardiac Arrhythmia
Statistical Analysis was performed using Prism 6 for MacOS X (GraphPad Software Inc, 2014). Univariate testing was performed using the Student’s t -test or the Mann–Whitney U test. Paired data were compared using the paired t -test.
Electrophysiological Profiling of Antiarrhythmic Drugs
Detailed Compound Sourcing for Studies
Comprehensive Pharmacological Screening Protocol
Pharmacological Assay for Ion Channels
Cardiac Electrophysiology in Drosophila
Cardiac Effects of Antiarrhythmic Drugs
Small Molecule Compound Synthesis and Evaluation
from Sigma-Aldrich (St. Louis, MO, USA). Test agent stock solutions were
prepared in 100% DMSO, and the final dilution was 1:1000 with culture media.
Comprehensive Pharmacological Compound Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!